NIH-funded research NIH-funded research

Single-cell phospho-proteomics to map breast tumor microenvironment

Official title: Single-cell (phospho-)proteomics platform for functional analysis of tumor microenvironment

Funded at Battelle Pacific Northwest Laboratories · NIH-11394417 · Data updated 2026-11-12

A researcher will develop a new, highly sensitive single-cell proteomics tool to map proteins and phosphorylation in breast cancer tumor environments, helping doctors tailor treatments.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionBattelle Pacific Northwest Laboratories
NIH-funded
Lab location1 site (Richland, United States)
Project startSeptember 1, 2025
Project endAugust 31, 2028
Funding year2026
Award (this year)$445,717
NIH project number5R33CA287139-02
Project IDNIH-11394417 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are adults with breast cancer whose tumors are accessible for biopsy or fresh tissue analysis.

Less likely to help

Patients whose tumors are not biopsied or whose tissue cannot be processed for single-cell proteomics may not benefit.

What this research studies

This project aims to profile individual cells within breast cancer tumors by measuring proteins and their phosphorylation patterns at the single-cell level. It will advance mass spectrometry methods to overcome current limits in sensitivity and phospho-enrichment, enabling a more complete view of the tumor microenvironment. By linking protein activity to cell types in the tumor, the work could inform personalized therapy decisions for patients with breast cancer.

Why it matters

Potential benefit: If successful, it could lead to more precise identification of actionable targets and better-informed treatment choices for breast cancer patients.

How similar studies have gone: Preliminary single-cell omics studies show the value of cell-level insights, but single-cell phospho-proteomics remains technically challenging and this work is pushing that boundary.

Where this research is happening

  • Battelle Pacific Northwest Laboratories
    Richland, United States
    Active

Researchers

  • Principal investigator: Shi, Tujin — Battelle Pacific Northwest Laboratories
  • Study coordinator: Shi, Tujin

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.